Published in Antimicrob Agents Chemother on February 01, 1972
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86
Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic. Antimicrob Agents Chemother (1977) 4.14
Compound 64716, a new synthetic antibacterial agent. Antimicrob Agents Chemother (1973) 4.11
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Susceptibility of Bacteroides fragilis to six antibiotics determined by standardized antimicrobial disc susceptibility testing. Antimicrob Agents Chemother (1973) 3.47
Cephalosporinase activity in Bacteroides fragilis. Antimicrob Agents Chemother (1973) 3.27
Aerobically incubated thioglycolate broth disk method for antibiotic susceptibility testing of anaerobes. Antimicrob Agents Chemother (1976) 3.17
Microdilution technique for antimicrobial susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1975) 2.83
Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis. J Bacteriol (1982) 2.80
Inactivation of cephalosporins by Bacteroides. Antimicrob Agents Chemother (1979) 2.75
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates. Antimicrob Agents Chemother (1974) 2.65
Clinical importance of infections due to Bacteroides fragilis and role of antibiotic therapy. Br Med J (1974) 2.49
Susceptibility of anaerobic bacteria to ten antimicrobial agents. Antimicrob Agents Chemother (1978) 2.45
Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics. Antimicrob Agents Chemother (1972) 2.42
Tryptic soy bile-kanamycin test for the indentification of Bacteroides fragilis. Appl Microbiol (1974) 2.36
Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob Agents Chemother (1977) 2.35
Bacteriostatic and bactericidal activities of various antibiotics against Bacteroides fragilis. Antimicrob Agents Chemother (1973) 2.34
Rapid microbiological assay for chloramphenicol and tetracyclines. Antimicrob Agents Chemother (1976) 2.26
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother (1990) 2.25
Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother (1975) 2.21
Isolation and characterization of multiply antibiotic-resistant Clostridum perfringens strains from porcine feces. Antimicrob Agents Chemother (1978) 2.11
Identification and antimicrobial susceptibility of 250 Bacteriodes fragilis subspecies tested by broth microdilution methods. Antimicrob Agents Chemother (1976) 2.09
Effect of preoperative antibiotic regimen on development of infection after intestinal surgery: Prospective, randomized, double-blind study. Ann Surg (1974) 2.03
Indirect fluorescent antibody procedure for the rapid detection and identification of Bacteroides and Fusobacterium in clinical specimens. J Clin Microbiol (1975) 1.83
Antibiotic susceptibility of the subspecies of Bacteroides fragilis. Antimicrob Agents Chemother (1976) 1.82
Resistance of some species of Clostridium to clindamycin. Antimicrob Agents Chemother (1973) 1.81
Incidence and significance of intraperitoneal anaerobic bacteria. Ann Surg (1975) 1.79
Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets. J Clin Microbiol (1979) 1.63
Beta-Lactamase activity in strains of Bacteroides melaninogenicus and Bacteroides oralis. Antimicrob Agents Chemother (1977) 1.62
Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline. Antimicrob Agents Chemother (1975) 1.59
Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods. Antimicrob Agents Chemother (1977) 1.46
A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg (1981) 1.45
Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species. Antimicrob Agents Chemother (1976) 1.44
Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens. Antimicrob Agents Chemother (1975) 1.43
Susceptibility of Propionibacterium acnes to seventeen antibiotics. Antimicrob Agents Chemother (1977) 1.42
Susceptibility of Clostridium ramosum to antimicrobial agents. Antimicrob Agents Chemother (1974) 1.39
Tetracycline resistance and TetM in oral anaerobic bacteria and Neisseria perflava-N. sicca. Antimicrob Agents Chemother (1988) 1.34
Treatment of severe bacteroides infections with parenteral clindamycin. Can Med Assoc J (1972) 1.32
Speed of bactericidal action of penicillin G, ampicillin, and carbenicillin on Bacteroides fragilis. Antimicrob Agents Chemother (1974) 1.31
Extrachromosomal elements in a variety of strains representing the Bacteroides fragilis group of organisms. Infect Immun (1976) 1.31
Economical agar dilution technique for susceptibility testing of anaerobes. Antimicrob Agents Chemother (1975) 1.28
Bacteroides infections. Ann Surg (1973) 1.23
Susceptibility of anaerobic bacteria to carbenicillin. Antimicrob Agents Chemother (1974) 1.17
Disk susceptibility testing of slow-growing anaerobic bacteria. Antimicrob Agents Chemother (1975) 1.17
In vitro activity of penicillins against anaerobes. Antimicrob Agents Chemother (1975) 1.14
Tetracycline-inducible transfer of tetracycline resistance in Bacteroides fragilis in the absence of detectable plasmid DNA. J Bacteriol (1982) 1.10
Fluorescent-antibody studies on selected strains of Bacteroides fragilis subspecies fragilis. J Clin Microbiol (1977) 1.04
Obligate anaerobes in clinical veterinary practice. J Clin Microbiol (1979) 1.03
Proposed standardized method for testing and interpreting susceptibility of Bacteroides fragilis to tetracycline. Antimicrob Agents Chemother (1974) 1.02
Rapid identification of Bacteroides fragilis with bile and antibiotic disks. J Clin Microbiol (1977) 1.02
Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species. Antimicrob Agents Chemother (1988) 1.02
In vitro susceptibilities of anaerobic bacteria to josamycin. Antimicrob Agents Chemother (1976) 1.02
Susceptibility of anaerobic bacteria to cofoxitin and related compounds. Antimicrob Agents Chemother (1977) 1.01
Chemotherapy of an experimental Bacteroides fragilis infection in mice. Antimicrob Agents Chemother (1977) 1.01
Treatment of anaerobic bacterial infections with clindamycin-2-phosphate. Antimicrob Agents Chemother (1974) 1.00
Incidence and isolation of Bacteroides species from clinical material and their sensitivity to antibiotics. J Clin Pathol (1973) 0.98
Bacteroides fragilis resistance to clindamycin in vitro. Antimicrob Agents Chemother (1982) 0.96
Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections. Antimicrob Agents Chemother (1985) 0.96
Tetracycline resistance in Peptostreptococcus species. Antimicrob Agents Chemother (1991) 0.95
Clindamycin--efficacy and toxicity. West J Med (1975) 0.95
Practical anaerobic broth-disk elution susceptibility test. Antimicrob Agents Chemother (1980) 0.95
Antibiotic-disc tests for rapid identification of non-sporing anaerobes. J Clin Pathol (1975) 0.92
Susceptibility of Clostridium perfringens isolated from human infections to twenty antibiotics. Antimicrob Agents Chemother (1977) 0.90
Gingival crevicular fluid levels of clindamycin compared with its minimal inhibitory concentrations for periodontal bacteria. Antimicrob Agents Chemother (1981) 0.90
Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy. Antimicrob Agents Chemother (1986) 0.89
Purification and characterization of a new beta-lactamase from Clostridium butyricum. Antimicrob Agents Chemother (1989) 0.89
Bilateral abscessed orchiepididymitis associated with sepsis caused by Veillonella parvula and Clostridium perfringens: case report and review of the literature. J Clin Microbiol (1987) 0.89
Complete genome sequence of Veillonella parvula type strain (Te3). Stand Genomic Sci (2010) 0.88
Non-vertebral Veillonella species septicemia and osteomyelitis in a patient with diabetes: a case report and review of the literature. J Med Case Rep (2014) 0.85
The possible role of anaerobic bacteria in the aetiology of non-gonococcal urethritis in men. Br J Vener Dis (1977) 0.85
Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis. Antimicrob Agents Chemother (1978) 0.82
Brain abscess. West J Med (1974) 0.82
Penetration into bone and tissues of clindamycin phosphate. Postgrad Med J (1978) 0.82
Stability in Escherichia coli of an antibiotic resistance plasmid from Bacteroides fragilis. J Bacteriol (1981) 0.81
Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria. Antimicrob Agents Chemother (1983) 0.80
Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks. Antimicrob Agents Chemother (1976) 0.78
Antibiotic lavage for peritonitis. Br Med J (1979) 0.75
Efficacy of intravenous clindamycin and methicillin in gram-positive soft tissue infections. Ann Surg (1975) 0.75
Clindamycin plus gentamicin as expectant therapy for presumed mixed infections. Can Med Assoc J (1976) 0.75
Treatment of Bacteroides infection with clindamycin-2-phosphate. Can Med Assoc J (1974) 0.75
Methods for testing antibiotic sensitivity of anaerobic bacteria. Infection (1980) 0.75
The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro. J Clin Pathol (1970) 6.02
Sensitivity of four species of bacteroides to antibiotics. Br Med J (1955) 5.87
Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. J Bacteriol (1967) 5.67
Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45
Bacteroides in intra-abdominal sepsis: their sensitivity to antibiotics. Lancet (1956) 4.05
A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis. J Clin Pathol (1968) 3.88
Bacteremic Bacteroides infections. Ann Intern Med (1970) 3.72
Lincomycin: activity against anaerobes and effect on normal human fecal flora. Antimicrob Agents Chemother (Bethesda) (1965) 3.29
Resistance of some strains of Bacteroides to ampicillin, methicillin and cloxacillin. Antonie Van Leeuwenhoek (1965) 3.16
The susceptibility of bacteroides to the penicillins and cephalothin. Am J Med Sci (1966) 2.52
Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J Bacteriol (1967) 2.21
Antibiotic susceptibility of bacteroides species. Antimicrob Agents Chemother (Bethesda) (1970) 1.78
Antibiotics for bacteroides sepsis. Ann Intern Med (1971) 1.67
The susceptibility of Clostridium perfringens type A to cephalosporin C antibiotics in vitro. Chemotherapy (1971) 1.58
Simplified method of anaerobic incubation. Appl Microbiol (1971) 1.44
Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12
Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16
Comparison of two commercially available media for detection of bacteremia. Appl Microbiol (1971) 11.61
Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28
Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10
Comparison of in vitro activity of cephalexin, cephradine, and cefaclor. Antimicrob Agents Chemother (1977) 7.14
Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc (1975) 7.01
Blood cultures: issues and controversies. Rev Infect Dis (1986) 6.95
Radiometric method for detection of bacteremia. Appl Microbiol (1971) 6.77
Clinical utility of thoracoscopy. Chest (1992) 6.34
Evaluation of radiometric system for detecting bacteremia. Appl Microbiol (1973) 6.26
Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J Clin Microbiol (1980) 5.99
Effects of atmosphere of incubation and of routine subcultures on detection of bacteremia in vacuum blood culture bottles. J Clin Microbiol (1975) 5.78
Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol (1983) 5.77
Multi-laboratory evaluation of an automated microbial detection/identification system. J Clin Microbiol (1978) 5.74
Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45
Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27
Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22
Evaluation of the Repliscan system for identification of Enterobacteriaceae. J Clin Microbiol (1978) 5.07
Blood cultures: principles and techniques. Mayo Clin Proc (1975) 4.87
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Effect of volume of blood cultured on detection of bacteremia. J Clin Microbiol (1976) 4.75
Comparison of two liquid blood culture media containing sodium polyanethole sulfonate: tryptic soy and Columbia. Appl Microbiol (1974) 4.52
Detection of bacteremia with liquid media containing sodium polyanetholsulfonate. Appl Microbiol (1974) 4.41
Microwave oven for melting laboratory media. J Clin Microbiol (1978) 4.33
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28
Clinical laboratory evaluation of automated microbial detection/identification system in analysis of clinical urine specimens. J Clin Microbiol (1979) 4.12
Evaluation of the necessity for routine terminal subcultures of previously negative blood cultures. J Clin Microbiol (1980) 4.08
The importance of volume of blood cultured in the detection of bacteremia and fungemia. Diagn Microbiol Infect Dis (1983) 4.05
Detection of fungi in blood cultures. J Clin Microbiol (1975) 4.05
Evaluation of two commercially available media for detection of bacteremia. Appl Microbiol (1972) 3.77
Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol (1971) 3.60
Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc (1974) 3.54
Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52
Recovery of yeast from vented blood culture bottles. J Clin Microbiol (1975) 3.42
Laboratory approaches to the identification of Enterobacteriaceae. Hum Pathol (1976) 3.30
Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis (1978) 3.29
Evaluation of a biphasic medium for blood cultures. J Clin Microbiol (1979) 3.23
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14
Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11
Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol (1976) 3.09
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol (1989) 2.96
Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am (1977) 2.94
Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis (1987) 2.93
Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A (1970) 2.89
Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87
Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86
Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85
In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82
Evaluation of blood culture media supplemented with sucrose or with cysteine. J Clin Microbiol (1975) 2.81
Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol (1975) 2.76
The in vitro spectrum of the cephalosporins. Mayo Clin Proc (1976) 2.72
Microbiological study of streptococcal bacteremia. Appl Microbiol (1973) 2.70
Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates. Antimicrob Agents Chemother (1974) 2.65
Coryneform bacterial endocarditis: difficulties in diagnosis and treatment, presentation of three cases, and review of literature. Mayo Clin Proc (1977) 2.63
Evaluation of the modified Micro-ID system for identification of Enterobacteriaceae. J Clin Microbiol (1979) 2.61
Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol (1971) 2.60
API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol (1979) 2.54
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53
Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51
Prevalence of serotypes of Salmonella. Appl Microbiol (1969) 2.50
Vaginal flora in asymptomatic women. Mayo Clin Proc (1976) 2.49
Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48
Evaluation of a routine anaerobic subculture of blood cultures for detection of anaerobic bacteremia. J Clin Microbiol (1978) 2.44
Diverticula of the Small Bowel. Ann Surg (1934) 2.44
Comparison of recovery of organisms from blood cultures diluted 10% (volume/volume) and 20% (volume/volume). J Clin Microbiol (1982) 2.42
Antimicrobial susceptibility of enterobacteriaceae and nonfermenting gram-negative bacilli. Mayo Clin Proc (1969) 2.41
Polymicrobial bacteremia. Ann Intern Med (1970) 2.40
The antimicrobial removal device. A microbiological and clinical evaluation. Am J Clin Pathol (1982) 2.40
Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis (1979) 2.37
Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37
Bacteroides bacteremia. Minn Med (1970) 2.36
Comparison of direct and standardized antimicrobial susceptibility testing of positive blood cultures. Antimicrob Agents Chemother (1976) 2.30
Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26
Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1980) 2.26
Controlled clinical evaluation of BACTEC Plus Aerobic/F and BacT/Alert Aerobic FAN bottles for detection of bloodstream infections. J Clin Microbiol (1995) 2.25
Optimal time for routine early subculture of blood cultures. J Clin Microbiol (1980) 2.24
Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24
Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. J Clin Microbiol (1996) 2.23
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23
Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis (1997) 2.17
Retrospective comparison of three blood culture media for the recovery of yeasts from clinical specimens. Eur J Clin Microbiol (1983) 2.15
Comparison of lysis-centrifugation with a biphasic blood culture medium for the recovery of aerobic and facultatively anaerobic bacteria. J Clin Microbiol (1984) 2.15
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12
Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12
Infections due to group C streptococci in man. Am J Med (1979) 2.08
Controlled clinical evaluation of Isolator and ESP aerobic blood culture systems for detection of bloodstream infections. J Clin Microbiol (1994) 2.07
Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli. Antimicrob Agents Chemother (1978) 2.07